Daniel Laeupple
Psychiatry · Madison, ALNPI 1669420865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 413 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,347 and has fallen 58.2% since, to $564 in 2025.
Across 413 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$855
- Johnson & Johnson$531
- Takeda Pharmaceuticals U.S.A., Inc.$491
- Axsome Therapeutics, Inc.$442
- Almatica Pharma LLC$430
- plus $3K from 23 others
What the payments were for
- Food & beverage$7,242100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 76 | $1,376 |
| Otsuka America Pharmaceutical, Inc. | 45 | $855 |
| Johnson & Johnson | 38 | $531 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $491 |
| Axsome Therapeutics, Inc. | 25 | $442 |
| Almatica Pharma LLC | 20 | $430 |
| Vanda Pharmaceuticals Inc. | 14 | $333 |
| Sunovion Pharmaceuticals Inc. | 28 | $331 |
| Corium, LLC | 18 | $296 |
| Lundbeck LLC | 15 | $288 |
| Alkermes, Inc. | 13 | $280 |
| Bausch Health US, LLC | 11 | $204 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $180 |
| Neos Therapeutics, LP | 9 | $169 |
| Teva Pharmaceuticals USA, Inc. | 8 | $133 |
| Eisai Inc. | 9 | $122 |
| Avanir Pharmaceuticals, Inc. | 6 | $108 |
| Idorsia Pharmaceuticals US Inc | 6 | $107 |
| Ironshore Pharmaceuticals Inc. | 6 | $103 |
| Tris Pharma Inc | 5 | $101 |
| Neurocrine Biosciences, Inc. | 5 | $87 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| Merck | 4 | $54 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Adlon Therapeutics L.p. | 3 | $37 |
| Neuronetics, Inc. | 2 | $33 |
| Shire North American Group Inc | 1 | $21 |
| Orexo US, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$7,245 in reported general payments places this provider in the 85th percentile of 400 psychiatry providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Asenapine Maleate | 14 | $3,656 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 59 | $2,113 |
| Trazodone Hcl | 83 | $1,037 |
| Alprazolam | 154 | $956 |
| Clonazepam | 120 | $849 |
| Doxepin Hcl | 11 | $836 |
| Quetiapine Fumarate | 98 | $793 |
| Buspirone Hcl | 36 | $730 |
| Olanzapine | 41 | $685 |
| Ziprasidone Hcl | 15 | $664 |
| Aripiprazole | 47 | $645 |
| Duloxetine Hcl | 20 | $627 |
| Bupropion Hcl SrBupropion Hcl | 27 | $431 |
| Fluoxetine Hcl | 63 | $424 |
| Temazepam | 13 | $422 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $430 | $24847 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 400 psychiatry providers in Alabama.
Other psychiatry in Madison
- Ammar AlrefaiMadison$16K
- Anika WilsonMadison$15K
- Justin ParrottMadison$14K
- Jun LiuMadison$7K
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
- Godehard OepenBirmingham$516K
- Scariya KumaramangalamHuntsville$440K
- Mark HaygoodMobile$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.